Analytics & Reports Center
AI-powered insights and analytics from your clinical trial documentation
AI-Generated Insights
Based on analysis of 1,247 documents across 8 active trials
• Documentation Quality Alert: Trial XCT-2023-45 has 12% more documentation gaps compared to similar Phase II oncology trials.
• Efficiency Finding: Your team is processing regulatory documents 28% faster than average using AI-assisted workflows.
• Risk Prediction: Based on current documentation patterns, there's a 76% probability of meeting the Q3 regulatory submission deadline.
Trial Documentation Health Scores
AI-generated quality assessment across active trials
- XCT-2023-44
-
94%Increased by 3%
- XCT-2023-45
-
76%Decreased by 5%
- XCT-2023-47
-
89%Increased by 2%
Custom Reports
Generate AI-enhanced reports from your documentation
-
Documentation Quality TrendsAI analysis of documentation completeness and accuracy over timeUpdated 2h ago
-
Protocol Compliance ReportAI-detected protocol deviations and compliance metricsUpdated 3d ago
-
Cross-Trial ComparisonAI-generated comparison of similar trials with key differencesIn progress
-
Regulatory Readiness AssessmentAI evaluation of documentation readiness for submissionScheduled
AI Processing Metrics
Performance and efficiency analytics
- Documents Processed (30 days)
- 1,247
-
18% from last month
- Average Processing Time
- 3.2 min
-
25% faster than manual
- Data Points Extracted
- 54,892
-
98.7% extraction accuracy
- Hours Saved (Estimated)
- 432
-
Compared to manual processing
AI Knowledge Framework Growth
Recently Generated Reports
Reports generated by your team using AI assistance
| Report Name | Generated By | Date | AI Enhancement | Actions |
|---|---|---|---|---|
|
Q1 Protocol Compliance Summary
XCT-2023-44, XCT-2023-45
|
Emily Johnson
Clinical Manager
|
April 15, 2025 | High Impact | View |
|
Documentation Gap Analysis
XCT-2023-47
|
Michael Chen
Regulatory Affairs
|
April 12, 2025 | High Impact | View |
|
Regulatory Submission Readiness
XCT-2023-44
|
Sarah Williams
Project Manager
|
April 8, 2025 | Medium Impact | View |
|
Protocol Amendment Impact Analysis
XCT-2023-45
|
James Rodriguez
Clinical Operations
|
April 5, 2025 | High Impact | View |